Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BACLOFEN USP, with a corresponding US DMF Number 18220.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 04, 2014, and payment made on March 28, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II